PPD Testing is Safe During First Trimester Pregnancy
The PPD (tuberculin skin test) is safe to perform during the first trimester of pregnancy and should not be delayed based on pregnancy alone, particularly in high-risk women.
Safety Evidence
The tuberculin skin test poses no risk to pregnant women or their fetuses at any stage of pregnancy, including the first trimester. The FDA drug label explicitly states that "TUBERSOL should be given to a pregnant woman only if clearly needed" 1, but this conservative language reflects standard pharmaceutical labeling rather than evidence of harm. More definitively, the American Thoracic Society/CDC guidelines clearly state there is "no evidence that the tuberculin skin test has adverse effects on the pregnant mother or fetus" 2.
When to Test During Pregnancy
Pregnant women should undergo PPD testing during the first trimester (or any trimester) if they have:
- Specific risk factors for latent TB infection (LTBI), such as:
- Immigration from high TB-prevalence countries
- Close contact with active TB cases
- HIV infection
- Immunosuppressive conditions
- Healthcare work or other high-risk occupational exposures
The antenatal period represents a valuable opportunity for screening, as immigrant women and other high-risk populations access medical care 3. Studies show high adherence rates with tuberculin testing during pregnancy (90-100%) 3.
Important Clinical Context
While the test itself is completely safe, the subsequent management decisions become more nuanced:
- Testing should be targeted, not universal, as pregnancy alone does not increase TB progression risk 2
- If the test is positive, treatment decisions for LTBI must weigh the risk of isoniazid hepatotoxicity (which may be increased during pregnancy and early postpartum) against progression risk 2
- For high-risk women (recent infection, HIV-positive), treatment should not be delayed even in the first trimester, with careful hepatitis monitoring 2
Practical Considerations
- The test requires a return visit for reading at 48-72 hours; self-reading is inaccurate 1
- Reactivity may be temporarily suppressed if live virus vaccines were given recently (delay testing >1 month) 1
- BCG vaccination history does not contraindicate testing, though interferon-gamma release assays may be preferred in BCG-vaccinated individuals ≥5 years old 1
Bottom line: Do not hesitate to perform PPD testing in the first trimester when clinically indicated—the test itself carries no fetal or maternal risk.